Follow
Aqsa Ikram
Aqsa Ikram
National university of science and technology
Verified email at imbb.uol.edu.pk
Title
Cited by
Cited by
Year
Exploring NS3/4A, NS5A and NS5B proteins to design conserved subunit multi-epitope vaccine against HCV utilizing immunoinformatics approaches
A Ikram, T Zaheer, FM Awan, A Obaid, A Naz, R Hanif, RZ Paracha, A Ali, ...
Scientific reports 8 (1), 16107, 2018
902018
Mutation-structure-function relationship based integrated strategy reveals the potential impact of deleterious missense mutations in autophagy related proteins on …
FM Awan, A Obaid, A Ikram, HA Janjua
International journal of molecular sciences 18 (1), 139, 2017
722017
Cross-reactivity towards SARS-CoV-2: the potential role of low-pathogenic human coronaviruses
Z Ma, P Li, Y Ji, A Ikram, Q Pan
The Lancet Microbe 1 (4), e151, 2020
572020
The emerging role and significance of circular RNAs in viral infections and antiviral immune responses: possible implication as theranostic agents
FM Awan, BB Yang, A Naz, A Hanif, A Ikram, A Obaid, A Malik, HA Janjua, ...
RNA biology 18 (1), 1-15, 2021
532021
Basal interferon signaling and therapeutic use of interferons in controlling rotavirus infection in human intestinal cells and organoids
MS Hakim, S Chen, S Ding, Y Yin, A Ikram, X Ma, W Wang, ...
Scientific reports 8 (1), 8341, 2018
392018
MicroRNA pharmacogenomics based integrated model of miR-17-92 cluster in sorafenib resistant HCC cells reveals a strategy to forestall drug resistance
FM Awan, A Naz, A Obaid, A Ikram, A Ali, J Ahmad, AK Naveed, ...
Scientific reports 7 (1), 11448, 2017
362017
Norovirus and rotavirus infections in children less than five years of age hospitalized with acute gastroenteritis in Indonesia
H Nirwati, CM Donato, Y Mawarti, NS Mulyani, A Ikram, AT Aman, ...
Archives of virology 164, 1515-1525, 2019
312019
Genotype-specific acquisition, evolution and adaptation of characteristic mutations in hepatitis E virus
A Ikram, MS Hakim, J Zhou, W Wang, MP Peppelenbosch, Q Pan
Virulence 9 (1), 121-132, 2018
282018
Does cross-neutralization of SARS-CoV-2 only relate to high pathogenic Coronaviruses?
Z Ma, P Li, A Ikram, Q Pan
Trends in immunology 41 (10), 851-853, 2020
182020
Model of the adaptive immune response system against HCV infection reveals potential immunomodulatory agents for combination therapy
A Obaid, A Naz, A Ikram, FM Awan, A Raza, J Ahmad, A Ali
Scientific reports 8 (1), 8874, 2018
182018
Immunity against hepatitis E virus infection: Implications for therapy and vaccine development
MS Hakim, A Ikram, J Zhou, W Wang, MP Peppelenbosch, Q Pan
Reviews in medical virology 28 (2), e1964, 2018
182018
Inhibitory potential of phytochemicals on interleukin-6-mediated T-cell reduction in COVID-19 patients: A computational approach
A Malik, A Naz, S Ahmad, M Hafeez, FM Awan, TH Jafar, A Zahid, A Ikram, ...
Bioinformatics and Biology Insights 15, 11779322211021430, 2021
162021
In silico identification and conservation analysis of B-cell and T-cell epitopes of hepatitis C virus 3a genotype enveloped glycoprotein 2 from Pakistan: A step towards …
A Ikram, S Anjum, M Tahir
Hepatitis Monthly 14 (6), 2014
152014
Systematically mapping clinical features of infections with classical endemic human coronaviruses
P Li, A Ikram, MP Peppelenbosch, Z Ma, Q Pan
Clinical Infectious Diseases 73 (3), 554-555, 2021
142021
Identification of drug resistance and immune-driven variations in hepatitis C virus (HCV) NS3/4A, NS5A and NS5B regions reveals a new approach toward personalized medicine
A Ikram, A Obaid, FM Awan, R Hanif, A Naz, RZ Paracha, A Ali, HA Janjua
Antiviral research 137, 112-124, 2017
142017
The impact of mutations on the pathogenic and antigenic activity of SARS-CoV-2 during the first wave of the COVID-19 pandemic: a comprehensive immunoinformatics analysis
Z Baloch, A Ikram, MS Hakim, FM Awan
Vaccines 9 (12), 1410, 2021
102021
HEV prevalence and potential risk factors in a large multi-ethnic youth cohort in China
H Li, Y Zhang, Z Ma, Z Liu, A Ikram, L Liu, G Zhao, Q Pan, Z Baloch
Virology Journal 18, 1-7, 2021
82021
An in silico deep learning approach to multi-epitope vaccine design: A hepatitis e virus case study
A Ikram, B Alzahrani, T Zaheer, S Sattar, S Rasheed, M Aurangzeb, ...
Vaccines 11 (3), 710, 2023
72023
Exploring NS3/4A, NS5A and NS5B proteins to design conserved subunit multi-epitope vaccine against HCV utilizing immunoinformatics approaches. Sci Rep 8: 16107
A Ikram, T Zaheer, FM Awan, A Obaid, A Naz, R Hanif, RZ Paracha, A Ali, ...
72018
Petri Net-Based Model of Helicobacter pylori Mediated Disruption of Tight Junction Proteins in Stomach Lining during Gastric Carcinoma
A Naz, A Obaid, FM Awan, A Ikram, J Ahmad, A Ali
Frontiers in Microbiology 8, 1682, 2017
72017
The system can't perform the operation now. Try again later.
Articles 1–20